medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2020, Número 2

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2020; 18 (2)


Evaluación de ácido hialurónico y coctel enzimático en cicatrices. Estudio multicéntrico

de Castro GMP, Muñoz MJR

Idioma: Español
Referencias bibliográficas: 38
Paginas: 84-92
Archivo PDF: 243.00 Kb.


RESUMEN

En este artículo se presentan y evalúan los resultados del tratamiento del producto ha 1.5 que contiene ácido hialurónico de alto peso molecular y un coctel de enzimas recombinantes colagenasa pb220, Lipasa pb500 y Liasa pb72k. El estudio realizado por 10 dermatólogos independientes a 42 pacientes que reportaron 44 fibrosis cicatriciales se analizó mediante una valoración facultativa, siguiendo la escala de Vancouver y la valoración de la percepción del paciente mediante la escala posas (Patient and Observer Scar Assesment Scale). Los resultados obtenidos revelan una excelente respuesta en todos los parámetros medidos desde la primera aplicación en la mayor parte de los pacientes tratados. Los resultados de seguridad del tratamiento muestran muy buen comportamiento con efectos adversos leves.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sheridan RL et al., Long-term outcome of children surviving massive burns, jama 2000; 283:69-73.

  2. Esselman PC, Burn rehabilitation: an overview, Arch Phys Med Rehabil 2007; 88:S3-S6.

  3. Li J, Chen J y Kirsner R, Pathophysiology of acute wound healing, Clin Dermatol 2007; 25:9.

  4. Reinke JM y Sorg H, Wound repair and regeneration, Eur Surg Res 2012; 49:35.

  5. Clark RA, Fibrin and wound healing, Ann NY Acad Sci 2001; 936:355-67.

  6. Ghazawi FM, Zargham R, Gilardino MS, Sasseville D y Jafarian F, Insights into the pathophysiology of hypertrophic scars and keloids: how do they differ, Adv Skin Wound Care 2018; 31:582-95.

  7. Wolfram D, Tzankov A, Pulzl P y Piza-Katzer H, Hypertrophic scars and keloids: a review of their pathophysiology, risk factors, and therapeutic management, Dermatol Surg 2009; 35:171-81.

  8. Berman B, Maderal A y Raphael B, Keloids and hypertrophic scars: pathophysiology, classification, and treatment, Dermatol Surg 2017; 43 Suppl 1:S3-S18.

  9. Bijlard E, Kouwenberg CA, Timman R, Hovius SE, Busschbach JJ y Mureau MA, Burden of keloid disease: a cross-sectional health-related quality of life assessment, Acta Derm Venereol 2017; 97:225-9.

  10. Kouwenberg CA, Bijlard E, Timman R, Hovius SE, Busschbach JJ y Mureau MA, Emotional quality of life is severely affected by keloid disease: pain and itch are the main determinants of burden, Plast Reconstr Surg 2015; 136:150-1.

  11. Al-Attar A, Mess S, Thomassen JM, Kauffman CL y Davison SP, Keloid pathogenesis and treatment, Plast Reconstr Surg 2006; 117:286-300.

  12. Berman B y Flores F, The treatment of hypertrophic scars and keloids, Eur J Dermatol 1998; 8:591-5.

  13. Anzarut A, Olson J, Singh P, Rowe BH y Tredget EE, The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis, J Plast Reconstr Aesthet Surg 2009; 62:77-84.

  14. Ogawa R, The most current algorithms for the treatment and prevention of hypertrophic scars and keloids, Plast Reconstr Surg 2010; 125:557-68.

  15. Van Leeuwen MC, Stokmans SC, Bulstra AE et al., Surgical excision with adjuvant irradiation for treatment of keloid scars: a systematic review, Plast Reconstr Surg Glob Open 2015; 3:e440.

  16. Tziotzios C, Profyris C y Sterling J, Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics Part ii. Strategies to reduce scar formation after dermatologic procedures, J Am Acad Dermatol 2012; 66:13-24; quiz 25.

  17. Wu WS, Wang FS, Yang KD, Huang CC y Kuo YR, Dexamethasone induction of keloid regression through effective suppression of vegf expression and keloid fibroblast proliferation, J Invest Dermatol 2006; 126:1264-71.

  18. Tang YW, Intra- and postoperative steroid injections for keloids and hypertrophic scars, Br J Plast Surg 1992; 45:371-3.

  19. Har-Shai Y, Brown W, Pallua N y Zouboulis CC, Intralesional cryosurgery for the treatment of hypertrophic scars and keloids, Plast Reconstr Surg 2010; 126:1798-800; réplica del autor: 1800.

  20. Har-Shai Y, Brown W, Labbe D et al., Intralesional cryosurgery for the treatment of hypertrophic scars and keloids following aesthetic surgery: the results of a prospective observational study, Int J Low Extrem Wounds 2008; 7:169-75.

  21. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A et al., Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study, J Am Acad Dermatol 2005; 52: 474-9.

  22. Nanda S y Reddy BS, Intralesional 5-fluorouracil as a treatment modality of keloids, Dermatol Surg 2004; 30(1):54-6; discusión: 56-7.

  23. Camacho-Martínez FM, Rey ER, Serrano FC y Wagner A, Results of a combination of bleomycin and triamcinolone acetonide in the treatment of keloids and hypertrophic scars, An Bras Dermatol 2013; 88:387-94.

  24. Gauglitz GG, Management of keloids and hypertrophic scars: current and emerging options, Clin Cosmet Investig Dermatol 2013; 6:103-14.

  25. Meyer LJ, Russell SB, Russell JD et al., Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts, J Invest Dermatol 2000; 114:953-9.

  26. Lorenz HP y Adzick NS, Scarless skin wound repair in the fetus, West J Med 1993; 159:350-5.

  27. Freund RM, Siebert JW, Cabrera RC et al., Serial quantitation of hyaluronan and sulfated glycosaminoglycans in fetal sheep skin, Biochem Mol Biol Int 1993; 29:773-83.

  28. King A, Balaji S, Le LD, Crombleholme TM y Keswani SG, Regenerative wound healing: the role of interleukin-10, Adv Wound Care (New Rochelle) 2014; 3:315-23.

  29. Evanko SP, Tammi MI, Tammi RH y Wight TN, Hyaluronan-dependent pericellular matrix, Adv Drug Deliv Rev 2007; 59:1351-65.

  30. Coolen NA, Schouten KC, Middelkoop E y Ulrich MM, Comparison between human fetal and adult skin, Arch Dermatol Res 2010; 302:47-55.

  31. Larson BJ, Longaker MT y Lorenz HP, Scarless fetal wound healing: a basic science review, Plast Reconstr Surg 2010; 126:1172-80.

  32. Namazi MR, Fallahzadeh MK y Schwartz RA, Strategies for prevention of scars: what can we learn from fetal skin?, Int J Dermatol 2011; 50:85-93.

  33. Malgorzata L, Krejner A y Tomasz G, Hyaluronic acid in inflammation and tissue regeneration, Wounds 2016; 28(3):78-88.

  34. Hoffmann A, Hoing JL, Newman M y Simman R, Role of hyaluronic acid treatment in the prevention of keloid scarring, J Am Col Clin Certif Wound Spec 2013; 4:23-31.

  35. Bae-Harboe YS, Harboe-Schmidt JE, Graber E y Gilchrest BA, Collagenase followed by compression for the treatment of earlobe keloids, Dermatol Surg 2014; 40:519-24.

  36. Kang N, Sivakumar B, Sanders R, Nduka C y Gault D, Intra-lesional injections of collagenase are ineffective in the treatment of keloid and hypertrophic scars, J Plast Reconstr Aesthet Surg 2006; 59:693-9.

  37. Tabola R, Augoff K, Grabowski K y Cirocchi R, Role of hyaluronidase in the treatment of hypertrophic scars, Dermatol Surg 2017.

  38. Dierickx C, Goldman MP y Fitzpatrick RE, Laser treatment of erythematous/ hypertrophic and pigmented scars in 26 patients, Plast Recost Surg 1995; 95:84-90.




2020     |     www.medigraphic.com